Wealthfront Advisers LLC raised its stake in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 10.8% in the first quarter, according to its most recent 13F filing with the SEC. The fund owned 21,327 shares of the semiconductor company’s stock after buying an additional 2,075 shares during the period. Wealthfront Advisers LLC’s holdings in Synopsys were worth $8,456,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also modified their holdings of SNPS. Sankala Group LLC acquired a new stake in Synopsys during the fourth quarter worth about $25,000. Thurston Springer Miller Herd & Titak Inc. acquired a new position in Synopsys in the fourth quarter valued at approximately $28,000. Caitong International Asset Management Co. Ltd acquired a new position in Synopsys in the fourth quarter valued at approximately $28,000. Atlas Capital Advisors Inc. purchased a new stake in Synopsys in the 4th quarter worth approximately $32,000. Finally, Geneos Wealth Management Inc. boosted its position in Synopsys by 151.5% in the 1st quarter. Geneos Wealth Management Inc. now owns 83 shares of the semiconductor company’s stock worth $33,000 after purchasing an additional 50 shares in the last quarter. Institutional investors and hedge funds own 85.47% of the company’s stock.
Wall Street Analyst Weigh In
A number of brokerages have recently commented on SNPS. Berenberg Bank set a $633.00 price objective on shares of Synopsys in a research note on Wednesday, May 27th. Rosenblatt Securities boosted their target price on shares of Synopsys from $530.00 to $575.00 and gave the company a “buy” rating in a research note on Tuesday, May 26th. Weiss Ratings reissued a “hold (c-)” rating on shares of Synopsys in a report on Monday, June 8th. Robert W. Baird set a $558.00 price target on shares of Synopsys in a research report on Thursday, May 28th. Finally, KeyCorp reaffirmed an “overweight” rating on shares of Synopsys in a report on Thursday, May 28th. Two research analysts have rated the stock with a Strong Buy rating, ten have assigned a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, Synopsys currently has an average rating of “Moderate Buy” and an average target price of $570.06.
Synopsys Stock Performance
Shares of SNPS stock opened at $384.27 on Friday. The company has a current ratio of 1.43, a quick ratio of 1.32 and a debt-to-equity ratio of 0.33. Synopsys, Inc. has a 12-month low of $366.00 and a 12-month high of $651.73. The business’s 50 day moving average is $469.31 and its two-hundred day moving average is $458.62. The company has a market capitalization of $73.58 billion, a P/E ratio of 88.95, a P/E/G ratio of 2.45 and a beta of 1.22.
Synopsys (NASDAQ:SNPS – Get Free Report) last posted its quarterly earnings data on Wednesday, May 27th. The semiconductor company reported $3.35 EPS for the quarter, beating analysts’ consensus estimates of $3.15 by $0.20. The business had revenue of $2.28 billion during the quarter, compared to analysts’ expectations of $2.25 billion. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.The business’s revenue was up 41.9% compared to the same quarter last year. During the same period in the previous year, the business earned $3.67 earnings per share. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. Analysts expect that Synopsys, Inc. will post 10.65 EPS for the current fiscal year.
Key Headlines Impacting Synopsys
Here are the key news stories impacting Synopsys this week:
- Positive Sentiment: Benchmark upgraded Synopsys (SNPS) to strong-buy, reinforcing a bullish long-term view on AI-driven demand for electronic design automation software. Zacks.com
- Positive Sentiment: Synopsys continues to have strong analyst support overall, with brokerage ratings averaging Moderate Buy and several recent price targets well above the current share price. American Banking News
- Neutral Sentiment: New commentary suggests the recent pullback may be a “buy the dip” opportunity, but that view is still based on technical support levels rather than a new fundamental catalyst. Trefis
- Negative Sentiment: SNPS is falling alongside a broader chip and tech selloff, which is weighing on sentiment across the semiconductor group. Benzinga
- Negative Sentiment: Investors are also worried about muted growth in Synopsys’s Design IP business and export-control headwinds, which may be limiting enthusiasm despite the earnings beat. Quiver Quantitative
Insiders Place Their Bets
In related news, CFO Shelagh Glaser sold 3,394 shares of the business’s stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the transaction, the chief financial officer directly owned 14,358 shares in the company, valued at approximately $6,461,387.16. The trade was a 19.12% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the business’s stock in a transaction that occurred on Monday, June 15th. The stock was sold at an average price of $458.96, for a total value of $6,702,192.88. Following the transaction, the chief executive officer owned 75,020 shares in the company, valued at approximately $34,431,179.20. This represents a 16.29% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Company insiders own 0.56% of the company’s stock.
About Synopsys
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Read More
- Five stocks we like better than Synopsys
- AST SpaceMobile Stock Sinks as SpaceX Fallout Rattles Space Sector
- Aehr Test Systems Stock Soars on Earnings, Eyes Over 150% Revenue Growth
- TSMC Just Gave AI Chip Bulls Another Reason to Stay Confident
- GE Aerospace Faces a Prove-It Moment in Q2 Earnings
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
